88IV - PR Newswire Asia's news


Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile – RECIST-based ORR of 38.5% (confirmed) and 46.2% (unconfirmed) ... 2026-04-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Mabwell Passes On-site GMP Inspection by Regulatory Authority of PIC/S Member Country (Jordan) for the First Time SHANGHAI , April 21, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its wholly-owned subsidiary, T-mab, ... 2026-04-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AACR 2026 Oral Presentation: Abogen Presents Preliminary Results of ABO2203 (mRNA-Encoded CD3×CD19 TCE) from First-in-Human Clinical Study in R/R B-NHL SAN DIEGO , April 20, 2026 /PRNewswire/ -- Abogen, a clinical-stage biotechnology company focused on RNA innovation, today announced preliminary clinical results from the first-in-human (FIH) study of ... 2026-04-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Pinnacle Food Group Limited Announces Entry Into a Non-Binding MOU to Explore Establishing an Open Yeast Platform Hub in Hong Kong VANCOUVER, BC and HONG KONG , April 20, 2026 /PRNewswire/ -- Pinnacle Food Group Limited (Nasdaq: PFAI), a technology-driven company operating at the intersection of smart agriculture and bio-engineering, ... 2026-04-20T Agriculture Biotechnology Food/Beverages
TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one owner Advancing felzartamab – a CD38-directed ... 2026-04-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Covation Biomaterials' First Commercial Plant for bioTHF and bioPTMEG Reaches Mechanical Completion; Xatryx®，Brand Unveiled for New Non-Food bioPTMEG SHANGHAI , April 20, 2026 /PRNewswire/ -- Covation Biomaterials LLC ("CovationBio ® "), a biomaterials company with advanced technology in the bio-based materials industry, announced ... 2026-04-20T Biotechnology Environmental Products & Services Green Technology
Immunofoco Presents Preclinical Data for IMV102, an In Vivo CAR-T Candidate, Demonstrating Durable Tumor Control at the AACR 2026 SHANGHAI , April 20, 2026 /PRNewswire/ -- Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. ... 2026-04-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fapon Biopharma Presents at AACR Annual Meeting 2026, Showcasing Core Technology Platforms and Advancing Pipeline SAN DIEGO , April 20, 2026 /PRNewswire/ -- Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the AACR ... 2026-04-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026 SHANGHAI , April 20, 2026 /PRNewswire/ -- AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha radiotherapies, today announced that ... 2026-04-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nuance Pharma Announces Publication of Phase 3 ENHANCE-CHINA Data in the CHEST Journal Ohtuvayre® (ensifentrine) helped improve lung function in Chinese adult patients in in data published in peer reviewed journal ... 2026-04-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology